DEPARTMENT OF HEALTH
Board of Osteopathic MedicineRULE NO: RULE TITLE
64B15-6.0038: FormularyNOTICE OF CORRECTION
The above-referenced rule notice was published in Vol. 35, No. 17, of the April 17, 2009, Florida Administrative Weekly. Although the rule notice stated that a Statement of Estimated Regulatory Costs (SERC) had been prepared and was available, the notice did not summarize the SERC. The following is a Summary of the Statement of Estimated Regulatory Costs:
1. The proposed change will allow Physician Assistants (PAs) to prescribe antipsychotics and parenteral preparations.
2. This rule change may affect up to 4,321 PAs and the physicians that supervise them.
3. The rule change will not require any government entity to incur additional costs or receive additional revenues.
4. No transactional costs will be incurred by any person or entity affected by this rule revision.
5. This proposed rule revision will have a positive impact on physician offices because it will expand access to direct patient care.
This correction does not affect the substance of the rule as it appeared in the Florida Administrative Weekly as outlined above. The person to be contacted regarding this rule is: Kaye Howerton, Executive Director, Board of Osteopathic Medicine, 4052 Bald Cypress Way, Bin #C06, Tallahassee, Florida 32399-3256.
